Literature DB >> 23105738

Hyperinsulinemia predisposes to NAFLD.

Sandhya Mishra1, Dharamveer Yadav, Monika Gupta, Hemant Mishra, Praveen Sharma.   

Abstract

Metabolic syndrome contributes to pathogenesis of Type-2 diabetes and CAD. Insulin Resistance is the key factor of metabolic syndrome implicated in development of Non Alcoholic Fatty Liver Disease (NAFLD). In present study we have investigated the prevalence of NAFLD in metabolic syndrome and contribution of metabolic risk factors in causation of NAFLD in non-diabetic North Indian male population. The study was conducted on 495 non-diabetic, nonalcoholic subjects (age 30-65 years). Metabolic Syndrome was assessed by using ATP III and ADA (2005) criteria. Anthropometric factors-Waist circumference and blood pressure were measured. Fasting serum samples were analyzed for Glucose, Triglycerides, Cholesterol and its fractions, Insulin, Alanine transaminase, Aspartate transaminase, Gamma glutamyl transferase and free fatty acids. Insulin resistance was estimated by Homeostasis Model and Insulin sensitivity by QUICKI Index. Liver ultrasonographic scanning was used for assessing fatty liver. The prevalence of metabolic syndrome and NAFLD was 24% and 14.8% respectively in non-alcoholic population and 27% of metabolic syndrome had NAFLD which was associated with hyperinsulinemia, insulin resistance, insulin insensitivity along with elevated levels of waist circumference, blood pressure, triglyceride, FFA and decreased HDL-Cholesterol. The prevalence of NAFLD increased with insulin resistance and clustering of metabolic risk factors.

Entities:  

Keywords:  Hyperinsulinemia; Insulin resistance; Metabolic Syndrome; NAFLD; Obesity

Year:  2008        PMID: 23105738      PMCID: PMC3453079          DOI: 10.1007/s12291-008-0030-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  28 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 2.  The metabolic syndrome: practical guide to origins and treatment: Part I.

Authors:  Peter W F Wilson; Scott M Grundy
Journal:  Circulation       Date:  2003-09-23       Impact factor: 29.690

3.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Authors:  Sasiwarang Goya Wannamethee; Andrew Gerald Shaper; Lucy Lennon; Peter H Whincup
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

4.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

5.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

6.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

7.  Non-alcoholic steatohepatitis in type 2 diabetes mellitus.

Authors:  Parijat Gupte; Deepak Amarapurkar; Subhash Agal; Rajiv Baijal; Pramod Kulshrestha; Snehansu Pramanik; Nikhil Patel; Aruna Madan; Anjali Amarapurkar
Journal:  J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 4.029

8.  Type-2 diabetes related intermediate phenotypic traits in north Indian diabetics.

Authors:  S K Mathur; Piyush Chandra; Sandhya Mishra; Peeyush Ajmera; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

9.  Oxidative stress in metabolic syndrome.

Authors:  Praveen Sharma; Sandhya Mishra; Peeyush Ajmera; Sandeep Mathur
Journal:  Indian J Clin Biochem       Date:  2005-01

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  6 in total

1.  A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.

Authors:  Sandhya Mishra; Dharamveer Yadav; Monika Gupta; Hemant Mishra; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2012-12-29

2.  Study of metabolic syndrome and its risk components in patients attending tertiary care center of uttarakhand.

Authors:  Rajeev Goyal; Ashok Kumar; Monil Singhai
Journal:  Indian J Clin Biochem       Date:  2013-07-28

Review 3.  Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease.

Authors:  Sneha Kothari; Hiteshi Dhami-Shah; Samir R Shah
Journal:  J Clin Exp Hepatol       Date:  2019-06-27

4.  Hyoscyamus albus nortropane alkaloids reduce hyperglycemia and hyperinsulinemia induced in HepG2 cells through the regulation of SIRT1/NF-kB/JNK pathway.

Authors:  Anna Kowalczuk; Nabila Bourebaba; Katarzyna Kornicka-Garbowska; Eliza Turlej; Krzysztof Marycz; Lynda Bourebaba
Journal:  Cell Commun Signal       Date:  2021-05-25       Impact factor: 5.712

5.  The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.

Authors:  Somaye Fatahi; Mohammad Hassan Sohouli; Appaji Rayi; Farshad Teymoori; Farzad Shidfar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

6.  The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).

Authors:  Yanyan Hu; Jinbo Chen; Lu Yang; Pin Chen; Juhong Li; Lin Chen; Jin Chen; Xiangqin Huang; Yaping Zhang; Shizhong Bu; Qin Huang
Journal:  J Clin Transl Endocrinol       Date:  2014-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.